
Focal therapy for prostate cancer proves as effective as radiotherapy, Clarkson and Cameron case highlights
An Imperial College London study shows focal therapy for localized prostate cancer—a minimally invasive treatment targeting only the tumor—offers decade-long cancer control comparable to radiotherapy or surgery with far fewer side effects; Clarkson and Cameron reportedly chose this approach, and UK funding is set to expand access to up to 15,000 eligible men per year (vs about 1,000 treated now), after the study found only two cancer deaths and a 3% spread rate a decade later.






